These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. [A case of acute hepatic failure in an HB carrier cured with long-term plasma exchange and interferon-beta treatment]. Kawasaki T; Fukuda Y; Ikehara Y; Nakayashiki H; Imoto S Nihon Shokakibyo Gakkai Zasshi; 1987 Sep; 84(9):1830-4. PubMed ID: 3430814 [No Abstract] [Full Text] [Related]
6. Approaches to the treatment of hepatitis B virus and delta-related liver disease. Thomas HC; Lever AM; Scully LJ; Pignatelli M Semin Liver Dis; 1986 Feb; 6(1):34-41. PubMed ID: 2424091 [No Abstract] [Full Text] [Related]
7. Alpha 2 recombinant interferon in the treatment of chronic hepatitis delta virus (HDV) hepatitis. Rosina F; Saracco G; Lattore V; Quartarone V; Rizzetto M; Verme G; Trinchero P; Sansalvadore F; Smedile A Prog Clin Biol Res; 1987; 234():299-303. PubMed ID: 3628384 [No Abstract] [Full Text] [Related]
8. The treatment of chronic type B viral hepatitis. Aach RD Ann Intern Med; 1988 Jul; 109(2):89-91. PubMed ID: 3289432 [No Abstract] [Full Text] [Related]
9. [The managements for asymptomatic carrier of hepatitis B virus]. Kuroki T; Nishiguchi S; So K; Harihara S Nihon Rinsho; 1995 Oct; 53 Suppl(Pt 2):420-6. PubMed ID: 12442420 [No Abstract] [Full Text] [Related]
10. Interferon therapy of complicated hepatitis B virus infection. Di Bisceglie AM Semin Liver Dis; 1989 Nov; 9(4):254-8. PubMed ID: 2690349 [No Abstract] [Full Text] [Related]
11. Immunoglobulin M antibody to hepatitis B core antigen (IgM anti-HBc) as a marker of interferon therapy in patients with persistent hepatitis B virus infection. Nakajima E; Tsuji T; Kachi K; Kagawa K; Okanoue T; Takino T; Yamada A; Imanishi J Biken J; 1987 Mar; 30(1):17-23. PubMed ID: 3675547 [TBL] [Abstract][Full Text] [Related]
12. Reactivation of hepatitis B virus by corticosteroids in a case of idiopathic nephrotic syndrome. Rostoker G; Rosenbaum J; Ben Maadi A; Nedelec G; Deforge L; Vidaud M; Lang P; Lagrue G; Goossens M; Weil B Nephron; 1990; 56(2):224. PubMed ID: 2243584 [No Abstract] [Full Text] [Related]
13. The role of hepatitis B surface antigen in the pathogenesis of glomerulopathies. Nagy J; Bajtai G; Brasch H; Süle T; Ambrus M; Deák G; Hámori A Clin Nephrol; 1979 Sep; 12(3):109-16. PubMed ID: 389501 [TBL] [Abstract][Full Text] [Related]
14. Interferon treatment of hepatitis B-associated membranous glomerulonephritis and nephrotic syndrome. Giboa N; Neigut D Pediatr Nephrol; 1993 Jun; 7(3):328-9. PubMed ID: 8518110 [No Abstract] [Full Text] [Related]
15. Hepatitis B carriers. Sloan DS N Z Med J; 1994 Dec; 107(991):515. PubMed ID: 7530355 [No Abstract] [Full Text] [Related]
16. [Effect of interferon on hepatitis B virus infection in patients with chronic active hepatitis]. Hinoue Y; Unoura M; Kato Y; Kobayashi K; Hattori N Gan To Kagaku Ryoho; 1984 Feb; 11(2):205-11. PubMed ID: 6696458 [TBL] [Abstract][Full Text] [Related]
17. [Treatment of viral hepatitis. b) Anti-virus agents]. Matsushima T Hokkaido Igaku Zasshi; 1984 May; 59(3):238-44. PubMed ID: 6479842 [No Abstract] [Full Text] [Related]
18. Glomerulonephritis associated with acute hepatitis B. Safadi R; Almog Y; Dranitzki-Elhalel M; Rosenmann E; Tur-Kaspa R Am J Gastroenterol; 1996 Jan; 91(1):138-9. PubMed ID: 8561114 [TBL] [Abstract][Full Text] [Related]
19. Human lymphoblastoid and fibroblast interferon in the treatment of chronic hepatitis B. Hayashi J; Noguchi A; Nakashima K; Hayashi S; Kashiwagi S; Mayumi T; Motomura M Clin Ther; 1990; 12(1):12-21. PubMed ID: 2328524 [TBL] [Abstract][Full Text] [Related]